Morgan Stanley’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.1K | Buy |
3,261
+1
| +0% | +$5 | ﹤0.01% | 6795 |
|
|
2026
Q1 | $10.6K | Hold |
3,260
| – | – | ﹤0.01% | 6923 |
|
|
2025
Q4 | $13K | Sell |
3,260
-345
| -10% | -$1.02K | ﹤0.01% | 6823 |
|
|
2025
Q3 | $11.2K | Sell |
3,605
-8,793
| -71% | -$29.2K | ﹤0.01% | 6870 |
|
|
2025
Q2 | $41.5K | Buy |
12,398
+9,738
| +366% | +$46.1K | ﹤0.01% | 6418 |
|
|
2025
Q1 | $11.3K | Hold |
2,660
| – | – | ﹤0.01% | 6766 |
|
|
2024
Q4 | $6.3K | Hold |
2,660
| – | – | ﹤0.01% | 6942 |
|
|
2024
Q3 | $3.4K | Hold |
2,660
| – | – | ﹤0.01% | 7012 |
|
|
2024
Q2 | $4.07K | Sell |
2,660
-8,614
| -76% | -$13.5K | ﹤0.01% | 6905 |
|
|
2024
Q1 | $18.9K | Sell |
11,274
-11,274
| -50% | -$22.5K | ﹤0.01% | 6507 |
|
|
2023
Q4 | $40.4K | Buy |
22,548
+11,274
| +100% | +$20.7K | ﹤0.01% | 6444 |
|
|
2023
Q3 | $21.3K | Hold |
11,274
| – | – | ﹤0.01% | 6461 |
|
|
2023
Q2 | $16.6K | Hold |
11,274
| – | – | ﹤0.01% | 6630 |
|
|
2023
Q1 | $22K | Sell |
11,274
-1
| -0% | -$2 | ﹤0.01% | 6590 |
|
|
2022
Q4 | $25.4K | Sell |
11,275
-1,619
| -13% | -$3.76K | ﹤0.01% | 6578 |
|
|
2022
Q3 | $31K | Buy |
12,894
+10,234
| +385% | +$24.1K | ﹤0.01% | 6605 |
|
|
2022
Q2 | $6K | Sell |
2,660
-495
| -16% | -$1.15K | ﹤0.01% | 7351 |
|
|
2022
Q1 | $9K | Buy |
3,155
+484
| +18% | +$1.61K | ﹤0.01% | 7432 |
|
|
2021
Q4 | $12K | Sell |
2,671
-501
| -16% | -$1.71K | ﹤0.01% | 7408 |
|
|
2021
Q3 | $8K | Buy |
3,172
+12
| +0.4% | +$36 | ﹤0.01% | 7389 |
|
|
2021
Q2 | $9K | Sell |
3,160
-8,000
| -72% | -$23.5K | ﹤0.01% | 7262 |
|
|
2021
Q1 | $34K | Buy |
11,160
+6,335
| +131% | +$20.6K | ﹤0.01% | 6520 |
|
|
2020
Q4 | $14K | Sell |
4,825
-3,677
| -43% | -$11.1K | ﹤0.01% | 6544 |
|
|
2020
Q3 | $27K | Sell |
8,502
-2,420
| -22% | -$7.96K | ﹤0.01% | 5942 |
|
|
2020
Q2 | $36K | Sell |
10,922
-1,246
| -10% | -$4.53K | ﹤0.01% | 5794 |
|
|
2020
Q1 | $44K | Sell |
12,168
-3,136
| -20% | -$14K | ﹤0.01% | 5511 |
|
|
2019
Q4 | $78K | Sell |
15,304
-683
| -4% | -$3.61K | ﹤0.01% | 5729 |
|
|
2019
Q3 | $95K | Sell |
15,987
-1,467
| -8% | -$8.16K | ﹤0.01% | 5461 |
|
|
2019
Q2 | $111K | Sell |
17,454
-1,531
| -8% | -$9.28K | ﹤0.01% | 5269 |
|
|
2019
Q1 | $110K | Buy |
18,985
+1,506
| +9% | +$8.73K | ﹤0.01% | 5349 |
|
|
2018
Q4 | $105K | Sell |
17,479
-2,035
| -10% | -$12.2K | ﹤0.01% | 5537 |
|
|
2018
Q3 | $111K | Buy |
19,514
+281
| +1% | +$1.66K | ﹤0.01% | 5654 |
|
|
2018
Q2 | $118K | Sell |
19,233
-1,182
| -6% | -$7.39K | ﹤0.01% | 5696 |
|
|
2018
Q1 | $137K | Buy |
20,415
+698
| +4% | +$4.8K | ﹤0.01% | 5619 |
|
|
2017
Q4 | $145K | Sell |
19,717
-336
| -2% | -$2.47K | ﹤0.01% | 5520 |
|
|
2017
Q3 | $142K | Sell |
20,053
-965
| -5% | -$6.67K | ﹤0.01% | 5477 |
|
|
2017
Q2 | $147K | Sell |
21,018
-597
| -3% | -$3.94K | ﹤0.01% | 5481 |
|
|
2017
Q1 | $150K | Buy |
21,615
+2,844
| +15% | +$17.2K | ﹤0.01% | 5447 |
|
|
2016
Q4 | $103K | Sell |
18,771
-12,473
| -40% | -$65.1K | ﹤0.01% | 5560 |
|
|
2016
Q3 | $157K | Sell |
31,244
-6,269
| -17% | -$29.5K | ﹤0.01% | 5110 |
|
|
2016
Q2 | $169K | Sell |
37,513
-2,901
| -7% | -$13.3K | ﹤0.01% | 5017 |
|
|
2016
Q1 | $181K | Sell |
40,414
-10,466
| -21% | -$49.9K | ﹤0.01% | 5038 |
|
|
2015
Q4 | $268K | Sell |
50,880
-6,280
| -11% | -$35.8K | ﹤0.01% | 4925 |
|
|
2015
Q3 | $330K | Sell |
57,160
-1,255
| -2% | -$7.82K | ﹤0.01% | 4835 |
|
|
2015
Q2 | $418K | Sell |
58,415
-7,453
| -11% | -$51.8K | ﹤0.01% | 4835 |
|
|
2015
Q1 | $438K | Buy |
65,868
+3,450
| +6% | +$21.5K | ﹤0.01% | 4753 |
|
|
2014
Q4 | $373K | Buy |
62,418
+65
| +0.1% | +$334 | ﹤0.01% | 4882 |
|
|
2014
Q3 | $308K | Sell |
62,353
-6,690
| -10% | -$32.4K | ﹤0.01% | 4889 |
|
|
2014
Q2 | $311K | Buy |
69,043
+2,544
| +4% | +$11.4K | ﹤0.01% | 4916 |
|
|
2014
Q1 | $299K | Sell |
66,499
-24,181
| -27% | -$115K | ﹤0.01% | 4889 |
|
|
2013
Q4 | $463K | Sell |
90,680
-61,444
| -40% | -$300K | ﹤0.01% | 4504 |
|
|
2013
Q3 | $689K | Sell |
152,124
-96,407
| -39% | -$480K | ﹤0.01% | 4097 |
|
|
2013
Q2 | $1.27M | Buy |
+248,531
| New | +$1.24M | ﹤0.01% | 3512 |
|
Other funds holding CPIX
VCM
VFT
BCM
Morgan Stanley's CPIX Position: Q2 2026 in Review
Morgan Stanley increased its Cumberland Pharmaceuticals (CPIX) stake by 0.03% in Q2 2026, buying an estimated $5 and bringing the position to 3,261 shares worth $21.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6795.
Morgan Stanley first reported a position in CPIX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.27M in Q2 2013. 21 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.
- Morgan Stanley held 3,261 shares of Cumberland Pharmaceuticals worth $21.1K as of Q2 2026.
- Morgan Stanley bought 1 Cumberland Pharmaceuticals share in Q2 2026, an estimated $5.
- Cumberland Pharmaceuticals made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #6795 holding.
- Morgan Stanley first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's Cumberland Pharmaceuticals position peaked at $1.27M in Q2 2013.
- 21 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.